Skip to main contentSkip to navigation
Sirius Investors
Rhoen-Klinikum AG

Rhoen-Klinikum AG

RHKJF
OTCHealthcare

Rhoen-Klinikum AG (RHKJF) Investment Research Dashboard

About Rhoen-Klinikum AG (RHKJF) stock analysis

Get live RHKJF stock price $15.30, comprehensive Rhoen-Klinikum AG stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time RHKJF stock data and investment insights.

15.30
0.00%Today
Market Cap
1.02B
Volume
0
52W High
15.30
52W Low
11.15

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

RHÖN-KLINIKUM Aktiengesellschaft, along with its associated companies, provides a comprehensive range of medical services across Germany. These services encompass full inpatient stays, partial hospitalization, and ambulatory care, catering to diverse...

Company Information

CEO
Stefan Stranz
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
19184

Contact Information

Address
Salzburger Leite 1
Country
DE

Investment Analysis & Business Insights

Healthcare
Medical - Care Facilities

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 21.6)

Lower volatility stock (Beta: -0.04) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Rhoen-Klinikum AG shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Rhoen-Klinikum AG
  • Investors should consider how Rhoen-Klinikum AG fits within their overall portfolio allocation

Market Cap

1.02B

P/E Ratio (TTM)

21.55

Beta

-0.04

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

78/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+3.1%+4.3%19.3
98/100⭐⭐⭐⭐⭐
Healthcare+0.7%+1.3%+1.6%24.1
78/100⭐⭐⭐⭐⭐
Communication Services+1.4%-0.7%+2.9%22.2
74/100⭐⭐⭐⭐⭐
Consumer Defensive-0.2%+1.8%+0.7%29.7
64/100⭐⭐⭐⭐
Basic Materials+0.4%+1.2%-0.2%25.2
61/100⭐⭐⭐⭐
Real Estate-0.5%+0.0%-2.5%29.2
43/100⭐⭐⭐
Energy-2.1%-3.7%-4.1%19.1
39/100⭐⭐
Utilities-1.0%+0.0%-4.4%26.8
37/100⭐⭐
Industrials+0.6%+0.4%-9.9%30.1
23/100
Consumer Cyclical+0.5%-1.5%-5.8%43.0
18/100
Technology+0.6%-1.6%-7.2%40.7
15/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.